|
|
Article: Cambridge Labs divests nabilone to Valeant.
- Article from:
- Pharma Marketletter
- Article date:
- February 26, 2007
CopyrightCOPYRIGHT 2007 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cambridge Laboratories, a privately-held UK drugmaker, has divested its interest in nabilone, a treatment for nausea and vomiting associated with cancer chemotherapy, to the USA's Valeant Pharmaceuticals. Cambridge ...
Related newspaper, magazine, and journal articles:
|
|
Article: Valeant Pharmaceuticals Announces Partnership ...
PR Newswire;
October 14, 2004 ;
700+ words
...Valeant Pharmaceuticals has announced two additional ... com/. About Valeant Valeant Pharmaceuticals International is a global ... plans or prospects for Valeant Pharmaceuticals. These statements are based ...
|
|